King George Medical University

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials
• Head and neck cancer1 trial
• IgA nephropathy1 trial
• Liver cirrhosis1 trial

Phase

• Phase 35 trials

Status

• Completed3 trials
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Biogen1 trial
• Boehringer Ingelheim1 trial
• King George's Medical University1 trial

Running trials

• Not yet recruiting

  Comparison of Rabeprazole and Vonoprazan in the Prevention of Post-endoscopic Variceal Ligation Ulcer in Patients With Cirrhosis

  NCT07608536· Phase 3· King George's Medical University· Source

  Contact: Dr Sumit Rungta, DM-Medical Gastroenterology

• Recruiting

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06935357· Phase 3· Biogen· Source

  Contact: US Biogen Clinical Trial Center

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• IgA nephropathy1 recruiting
• Liver cirrhosis1 recruiting

Closed trials

• Completed

  A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03524092· Phase 3· Eli Lilly and Company· Source

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source

• Completed

  LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

  NCT01856478· Phase 3· Boehringer Ingelheim· Source